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To evaluate the effect of introduction of iterative reconstruction as a mandated software
upgrade on radiation dosimetry in routine clinical practice over a range of computed tomog-
raphy examinations.
Methods
Random samples of scanning data were extracted from a centralised Picture Archiving
Communication System pertaining to 10 commonly performed computed tomography
examination types undertaken at two hospitals in Western Australia, before and after the
introduction of iterative reconstruction. Changes in the mean dose length product and effec-
tive dose were evaluated along with estimations of associated changes to annual cancer
incidence.
Results
We observed statistically significant reductions in the effective radiation dose for head com-
puted tomography (22–27%) consistent with those reported in the literature. In contrast the
reductions observed for non-contrast chest (37–47%); chest pulmonary embolism study
(28%), chest/abdominal/pelvic study (16%) and thoracic spine (39%) computed tomogra-
phy. Statistically significant reductions in radiation dose were not identified in angiographic
computed tomography. Dose reductions translated to substantial lowering of the lifetime
attributable risk, especially for younger females, and estimated numbers of incident
cancers.
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Conclusion
Reduction of CT dose is a priority Iterative reconstruction algorithms have the potential to
significantly assist with dose reduction across a range of protocols. However, this reduction
in dose is achieved via reductions in image noise. Fully realising the potential dose reduc-
tion of iterative reconstruction requires the adjustment of image factors and forgoing the
noise reduction potential of the iterative algorithm. Our study has demonstrated a reduction
in radiation dose for some scanning protocols, but not to the extent experimental studies
had previously shown or in all protocols expected, raising questions about the extent to
which iterative reconstruction achieves dose reduction in real world clinical practice.
Introduction
The relatively high doses received by patients from Computed Tomography (CT) were first
highlighted in 1991 when estimates of organ and effective doses for common CT procedures
on adults were reported in the UK.[1] These data provided the basis for reference doses pub-
lished in 1999 as part of European guidelines on quality criteria for CT.[2] While it is recog-
nised that advances in CT technology, such as the development of fast, helical scanning using
multidetector rows / multislice have facilitated increasing clinical application of CT leading to
significant improvements in health care for populations, concerns persist regarding the radia-
tion dose to both populations and individuals from CT.
In the late 1990’s despite comprising only 2% of all medical imaging examinations, CT was
shown to contribute a disproportionately large proportion (20%) of the collective population
dose from diagnostic imaging.[3, 4] Surveys such as those conducted by the UK National
Radiological Protection Board,[3, 5] also indicated that doses from CT were trending in a direc-
tion at odds with the decreasing collective patient doses received from conventional x-ray
examinations.[3] During the 1990’s and early 2000’s CT examinations grew steadily to become
a significant source of population exposure from medical radiology.[4] For example, in the UK,
CT doubled both its contribution to the population effective dose (47%) and the proportion of
all radiological examinations (4%) over a 10 year period.[6] Similar findings were reported in
other developed countries such as Switzerland,[7] Germany,[8] the Netherlands [9] and the
US.[10] In 2009 National Council on Radiation Protection and Measurements (NCRP)
reported that CT and nuclear medicine contributed 36% of the total radiation exposure and
75% of the medical radiation exposure of the U.S. population.
As a result of these concerns the radiological community has made significant effort to
reduce CT radiation dose via strategies such as tube-current modulation,[11] over-beam reduc-
tion,[12] organ-specific dose reduction (e.g. tilted gantry acquisitions)[13] and protocol opti-
mization.[14] More recently an effort to reduce CT dose using iterative algorithms for image
reconstruction has been pursued.[15–19] The algorithms have been shown to be capable of
reducing image noise and thus in principle the radiation dose[16, 17] in the head,[17, 20, 21]
chest,[22–28] abdomen[29–36] and CT angiography.[37–43] While these studies have shown
the potential to significantly reduce radiation dose at the expense of forgoing a proportion of
the noise reduction achievable using iterative reconstruction algorithms, the majority have
been focussed on image optimization conducted in an experimental setting using either phan-
toms or very small samples of patients.
Since the amount of noise contained within the image is inversely proportional to the square
root of the radiation dose[17] it follows that the potential for dose reduction using iterative
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reconstruction methods is directly related to the degree of noise acceptable to the radiologist.
To date estimations of reductions in radiation dose achievable using iterative reconstruction
methods have aimed to determine the maximum amount of noise that maintains acceptable
diagnostic accuracy. Unfortunately due to the artificial/experimental circumstances of these
studies the findings may not be representative of the degree of noise reduction acceptable in
routine clinical practice. Thus the reduction in radiation dose indicated by these studies may
not be realised or sustainable in a “real world” environment. Since any reduction in radiation
dose mediated by iterative reconstruction requires negotiation and agreement regarding the
associated changes in image quality by radiologists, a structured multidisciplinary implementa-
tion plan has been advocated.[44] The aim of this study was to evaluate the effect of introduc-
tion of an iterative reconstruction algorithm in the context of a mandated software upgrade on
radiation dosimetry in routine clinical practice over a range of CT examinations.
Methods
This was an observational study in the form of a natural experiment involving retrospective
extraction of technical CT scanning data from a centralised Picture Archiving Communication
System (PACS). Data were collected from scans undertaken at one secondary and one tertiary
public hospital in Western Australia (WA) before and after the introduction of iterative recon-
struction software (iDose, a hybrid iterative reconstruction algorithm) as a software upgrade
initiated by the Department of Health level for all Philips Healthcare CT equipment in WA
public hospitals. Upon introduction, iterative reconstruction was available for use as an alter-
native reconstruction algorithm. No systematic sustained implementation activities were
undertaken to incorporate the new software into clinical practice. Both hospital sites had the
same make and model 64 slice CT scanner. The secondary hospital had a single CT machine
while the tertiary hospital had two identical machines. The study was approved by the Western
Australian Department of Health Human Research Ethics Committee (#2011/97), with a
waiver of informed consent for the retrospective review of electronic medical records.
Data sources
Baseline (pre introduction of iterative reconstruction software) de-identified data were
extracted manually from information contained in the dose report images for CT scans under-
taken between 1st January and 31st May 2010 at both hospitals. Iterative reconstruction soft-
ware was fully installed at both hospitals by the end of the first quarter of 2012 and data were
extracted for the post installation phase from CT scans undertaken between September and
November 2012 to allow sufficient time for use of the software to become imbedded into stan-
dard practice. For both pre and post software installation data capture periods a random sam-
ple of 20 adult cases from each of the CT examination types listed below (identified using the
WA standardised CT coding system used in the PACS) provided data from both hospital
unless indicated otherwise. Rarely fewer than twenty cases were identified within the collection
period; in this event all cases were included in the study. If the technical parameters appeared
particularly variable up to forty cases were collected. A sample of 20 cases is at least double
studies using self-report data have used[6] is comparable in size to other studies[45], conforms
to the European guidelines regarding the sample of cases required to assess dosimetry of usual
practice and is consistent with the sample size used during estimation of Australian diagnostic
reference levels [46, 47]) This random sampling method and sample size per protocol has also
been used by the research team in previous studies [48, 49].The examination types included in
the study were chosen because they represent approximately 70% of CT scans undertaken in
WA.
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1. Head non-contrast
2. Chest non-contrast
3. Chest pulmonary embolism (PE) study
4. CT angiogram thoracic aorta
5. CT coronary angiogram–Tertiary hospital only
6. Abdomen/Pelvis non-contrast
7. CT visceral angiogram—Tertiary hospital only
8. Chest/Abdo/Pelvis non-contrast—Tertiary hospital only
9. CT thoracic spine—Tertiary hospital only
10. CT lumbar spine
Protocol information (excluding the scout view) consisted of separate scanning sequences
(phases) whenever present. The technical parameters collected included anatomical reference
start-stop positions, volume weighted CT dose index (CTDIvol) and dose–length product
(DLP).
Radiation Dosimetry
Values of CTDIvol (inclusive of automated tube current modulation) and DLP were used to
calculate the effective dose (mSv) for each sequence using the ImPACT dosimetry calculation
software[50] as described previously.[48, 49, 51] The ImPACT dosimetry calculation software
employs CT machine specific dosimetrics based on International Commission on Radiological
Protection (ICRP) 103 tissue weighting factors[50, 52]. This tool allows organ and effective
dose to be estimated in a population of patients based on Monte Carlo simulation in an ideal-
ized phantom. Justification of this method and its limitations are presented in the discussion
section. Where appropriate cumulative protocol values of CTDIvol, DLP, organ dose and effec-
tive dose were calculated by summation of all sequences (phases) reported for each case.
Effect of Iterative Reconstruction on CT Dose Metrics
The statistical significance of changes in the mean DLP and effective dose were evaluated sepa-
rately for each CT examination type using the Mann-Whitney U test in each hospital setting
and across both hospitals where CT examination types were undertaken by both hospitals. The
Mann-Whitney U test is a rank-order test (or nonparametric test) for assessing the distribution
of two independent groups when combined into a single sample (ie, whether the scores of two
independent groups have a similar ranked distribution) not differences of means or medians.
The test assesses the location and range of the lowest group's distribution within the overall
sample range[53], and contrast this against a theoretical ranked distribution approaching nor-
mal ('U' or 'z' distribution, depending on sample size). The test is also powerful in detecting dif-
ferences between group means and is commonly portrayed as the non-parametric substitute
for Student's t-test when samples are not normally distributed[53]. This analysis was per-
formed using SPSS version 19.
Cancer Risk Modelling
In order to evaluate the impact on risk burden, of any statistically significant changes in effec-
tive dose, the age and Sex specific lifetime attributable risk (LAR) of cancer incidence pre and
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post installation of iterative reconstruction software was calculated in Microsoft Excel. This
was achieved using the protocol specific organ dose and the age/sex-specific risk coefficients
from table 12D-1 of the BEIR VII report[54]. The LAR of cancer incidence resulting from radi-
ation dose to the remainder and ‘other’ organs was calculated using doses for organs included
in the remainder organs by ICRP 103[52], and weighting them by the risk attributed by BEIR
VII for ‘other’ organs. This method assumes all such organs contribute equally to risk which is
clearly an approximation. The analysis was repeated for all combinations of age (ranging from
15 to 80 years) in yearly increments, using linear interpolation of the BEIR VII risk coefficients
from the two nearest tabulated ages when data were not available for a specific age. The change
in the LAR associated with the introduction of iterative reconstruction software was calculated
as the difference between the two LAR estimates.
Estimation of Potential Changes to Annual Cancer Incidence
Counts of the total number of CT examinations undertaken in Western Australia between 1st
January 2010 and 31st December 2012 on adults aged 18+ years according to Sex and age for
the examination types included were obtained fromMedicare Australia (CT scan undertaken
in the private sector) and the Western Australia PACS (CT scans undertaken in the public sec-
tor). For each CT examination scenario the average annual Sex/ age specific number of exami-
nations was multiplied by the appropriate change in LAR observed in our study. The purpose
of undertaking this analysis was to demonstrate that even small to modest reductions in radia-
tion dose can have large impacts upon risk at the population level depending upon the Sex and
age of the patients involved.
Results
The mean, median, standard deviation, minimum and maximum values together with the min-
imum to maximum ratio for DLP and effective dose are reported in Tables 1 and 2 respectively
for each examination type before and after the introduction of iterative reconstruction software
according to hospital type. Absolute and relative changes in the mean DLP and effective dose
differed according to CT examination and hospital.
Following introduction of iterative reconstruction software in the secondary hospital there
were moderate reductions in mean DLP and effective dose in Head non-contrast, Chest non-
contrast and Chest PE studies and very small reductions for Angiogram Thoracic Aorta. In
contrast, an increase in both mean DLP and effective dose was observed for CT Lumbar spine
and Abdomen/Pelvis non-contrast. Across all examination types, except lumbar spine, a reduc-
tion in the dispersion from the mean (standard deviation) for both metrics was observed.
In the tertiary hospital, reductions in the mean DLP and effective dose values were observed
for Head non-contrast, Chest non-contrast, Chest PE study, Coronary Angiogram, Chest/
Abdomen/Pelvis and Thoracic procedures. Increases in both dose metrics were observed for
CT Angiography of the Thoracic Aorta, Abdomen/Pelvis CT and CT Angiogram Visceral.
Changes in the dispersion of both metrics mirrored changes in the mean values i.e. when a
reduction in the mean was observed a reduction in the standard deviation was also observed
and vice versa.
When changes in radiation dosimetry were evaluated for CT examinations undertaken at
both hospitals reductions in both the DLP and effective dose were observed for Head non con-
trast, Chest non-contrast and Chest PE study. However, increases in both metrics were
observed for CT Angiography of the Thoracic Aorta, Abdomen/Pelvis CT and Lumbar spine
CT. Changes in dispersion varied across the dose metrics with changes mirroring changes in
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Table 1. Mean, median and dispersion of dose length product (mGy.cm) according to CT scanning protocol before and after the introduction of
iterative reconstruction (iDose).
Before iDose software installation Following iDose software installation
Protocol
Description
n Mean Median St. Dev. Min Max Min:
Max
Ratio







30 826.38 812.90 111.81 500.30 988.30 2.0 20 651.46 626.20 72.89 575.80 912.10 1.6
Chest (Non-
Contrast)
20 433.18 412.95 162.20 161.80 664.90 4.1 20 282.88 248.60 119.42 62.10 473.20 7.6
Chest PE Study 21 501.92 315.40 520.84 159.80 2499.70 15.6 20 358.74 259.25 266.60 117.40 1157.60 9.9
Angiogram
Thoracic Aorta
20 1304.01 1153.05 559.47 224.80 3017.00 13.4 20 1224.69 1247.95 490.69 510.40 2084.30 4.1
Angiogram
Coronary




20 568.10 531.50 309.17 156.70 1386.40 8.8 20 620.91 607.90 275.99 148.60 1187.00 8.0
Angiogram
Visceral




- - - - - - - - - - - - - -
Thoracic Spine - - - - - - - - - - - - - -




20 1207.76 898.55 647.32 842.30 2699.20 3.2 20 911.77 961.50 114.06 659.90 1055.60 1.6
Chest (Non-
Contrast)
20 435.04 308.15 404.93 146.30 1872.90 12.8 19 224.33 176.60 176.27 28.30 583.40 20.6
Chest PE Study 20 738.23 747.45 329.85 41.80 1635.70 39.1 20 523.32 508.60 188.74 192.90 878.10 4.6
Angiogram
Thoracic Aorta
20 799.86 830.20 352.21 192.40 1596.10 8.3 19 1029.48 1111.60 458.34 207.70 1938.80 9.3
Angiogram
Coronary




20 564.48 589.65 339.58 103.40 1169.10 11.3 19 593.59 530.90 344.28 110.70 1384.60 12.5
Angiogram
Visceral




10 997.21 832.40 415.11 463.40 1816.70 3.9 19 605.56 476.40 576.74 272.50 2921.80 10.7
Thoracic Spine 10 1032.26 1053.60 443.58 374.70 1787.90 4.8 19 629.91 479.40 527.08 158.20 1990.10 12.6




50 978.93 842.50 453.32 500.30 2699.20 5.4 40 781.61 701.90 162.17 575.80 1055.60 1.8
Chest (Non-
Contrast)
40 434.11 346.30 304.47 146.30 1872.90 12.8 39 254.36 234.00 150.76 28.30 583.40 20.6
Chest PE Study 41 617.20 546.40 449.02 41.80 2499.70 59.8 40 441.03 380.95 242.75 117.40 1157.60 9.9
Angiogram
Thoracic Aorta
40 1051.94 1049.20 527.35 192.40 3017.00 15.7 39 1129.59 1227.20 479.24 207.70 2084.30 10.0
(Continued)
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the mean for effective dose; however DLP dispersion reduced in all examination types except
CT of the Lumbar spine.
Statistical Analysis of Changes in Dose Metrics
Table 3 shows the results of evaluating the statistical significance of the changes in the mean
DLP and effective dose following introduction of iterative reconstruction software. In the sec-
ondary hospital statistically significant reductions in both the mean DLP and effective dose
were only observed for Head non-contrast (-21% averaged over both metrics); and Chest non-
contrast (-36% averaged over both metrics) examinations. In the tertiary hospital, while a sta-
tistically significant 27% reduction in the mean effective dose was observed in Head non-con-
trast CT examinations, the observed reduction in DLP of 24% was not statistically significant.
In this setting statistically significant reductions in both metrics was observed for Chest (Non-
Contrast) (-47% averaged over both metrics), Chest PE study (-28% averaged over both met-
rics), Chest/Abdo/Pelvis (Non-Contrast) (-27% averaged over both metrics) and CT of the
Thoracic spine (-40% averaged over both metrics). With respect to examination undertaken at
both hospitals two examination types showed statistically significant reductions in both DLP
and effective dose, namely: Head non-contrast (-21% averaged over both metrics), Chest non-
contrast (-41%) and Chest PE study (-28%).
Impact on LAR by Statistically Significant Changes in Effective Dose
Fig 1 shows the effect of the introduction of iterative reconstruction on risk of cancer for those
examinations showing a significant difference in effective dose in the secondary hospital. The
figure shows the effect on the estimated number of incident cancers per 100,000 examinations
resulting from the change in effective dose attributed to introduction of iterative reconstruction
according to Sex and age at the examination. It can be appreciated that for both examinations
the significant reduction in the mean effective dose associated with the introduction of iterative
reconstruction has translated to a reduction in the estimated number of incident cancers in
both sexes (females to a greater extent than males) and that the magnitude of the reduction is
greater at younger age groups. For CT head non-contrast the reduction in mean effective dose
Table 1. (Continued)
Before iDose software installation Following iDose software installation
Protocol
Description
n Mean Median St. Dev. Min Max Min:
Max
Ratio









40 566.29 542.30 320.54 103.40 1386.40 13.4 39 607.25 571.20 308.29 110.70 1384.60 12.5
Angiogram
Visceral




- - - - - - - - - - - - - -
Thoracic Spine - - - - - - - - - - - - - -
Lumbar Spine 30 744.07 631.10 440.00 296.10 2480.40 8.4 39 881.11 753.30 519.75 268.30 2852.50 10.6
n = Number of cases included in analysis. Min = Minimum value, Max = Maximum value.
doi:10.1371/journal.pone.0138329.t001
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of 0.36mSv translated to 6.5 fewer incident cancers per 100,000 males and 8 fewer incident can-
cers per 100,000 females at age 15 years reducing to 0.7 per 100,000 regardless of Sex at age
Table 2. Mean, median and dispersion of effective dose (mSv) according to CT scanning protocol before and after the introduction of iterative
reconstruction (iDose).
Before iDose software installation Following iDose software installation
Protocol Description n Mean Median St. Dev. Min Max Min:Max
Ratio
n Mean Median St. Dev. Min Max Min:Max
Ratio
Secondary Hospital
Head (Non-Contrast) 30 1.61 1.59 0.14 1.00 1.70 1.7 20 1.25 1.25 0.00 1.30 1.30 1.0
Chest (Non-Contrast) 20 8.57 8.00 3.43 2.96 13.97 4.7 20 5.44 4.85 2.14 2.29 9.27 4.0
Chest PE Study 21 9.88 6.43 10.10 0.48 48.70 101.9 20 7.07 5.19 4.89 2.38 22.44 9.4
Angiogram Thoracic
Aorta
20 23.15 21.90 7.77 5.50 45.25 8.2 20 22.17 22.89 7.29 9.54 32.07 3.4
Angiogram Coronary - - - - - - - - - - - - - -
Abdomen +/- Pelvis
(Non-Contrast)
20 9.07 8.53 4.33 3.74 19.81 5.3 20 10.29 9.38 4.46 4.08 18.90 4.6
Angiogram Visceral - - - - - - - - - - - - - -
Chest/Abdo/Pelvis (Non-
Contrast)
- - - - - - - - - - - - - -
Thoracic Spine - - - - - - - - - - - - - -
Lumbar Spine 20 11.98 11.08 4.15 5.98 23.05 3.9 20 14.33 10.99 7.13 6.31 33.42 5.3
Tertiary Hospital
Head (Non-Contrast) 20 2.37 2.12 0.85 1.50 4.38 2.9 20 1.74 1.81 0.25 1.30 2.20 1.7
Chest (Non-Contrast) 20 7.93 5.81 8.21 2.54 41.09 16.2 19 4.21 3.51 3.53 0.57 12.22 21.5
Chest PE Study 20 14.60 14.94 6.62 0.83 32.46 39.0 20 10.48 10.61 3.46 3.49 17.50 5.0
Angiogram Thoracic
Aorta
20 14.48 13.25 5.69 3.37 26.05 7.7 19 19.40 19.67 9.53 6.18 35.35 5.7
Angiogram Coronary 20 15.57 12.25 10.06 4.41 32.54 7.4 20 11.24 10.06 5.31 3.44 23.95 7.0
Abdomen +/- Pelvis
(Non-Contrast)
20 9.69 9.71 5.41 2.06 19.76 9.6 19 9.96 9.53 5.59 2.00 26.11 13.1
Angiogram Visceral 20 31.17 31.05 15.22 0.63 59.20 93.7 20 37.19 33.07 15.95 5.63 64.38 11.4
Chest/Abdo/Pelvis (Non-
Contrast)
10 17.34 14.63 6.55 9.26 31.04 3.4 19 14.53 7.93 27.04 4.77 125.66 26.3
Thoracic Spine 10 21.15 20.18 9.14 6.72 35.40 5.3 19 12.90 9.53 9.08 5.81 42.70 7.4
Lumbar Spine 10 15.02 14.68 4.13 10.08 22.80 2.3 19 16.09 13.01 9.74 5.24 43.94 8.4
Both Hospitals
Head (Non-Contrast) 50 1.91 1.73 0.66 1.00 4.40 4.4 40 1.50 1.28 0.30 1.30 2.20 1.7
Chest (Non-Contrast) 40 8.25 6.73 6.22 2.54 41.09 16.2 39 4.84 4.34 2.93 0.57 12.22 21.5
Chest PE Study 41 12.18 10.65 8.81 0.48 48.70 101.9 40 8.77 8.54 4.52 2.38 22.44 9.4
Angiogram Thoracic
Aorta
40 18.81 19.71 8.03 3.37 45.25 13.4 39 20.82 21.79 8.46 6.18 35.35 5.7
Angiogram Coronary - - - - - - - - - - - - - -
Abdomen +/- Pelvis
(Non-Contrast)
40 9.38 8.87 4.84 2.06 19.81 9.6 39 10.13 9.53 5.00 2.00 26.11 13.1
Angiogram Visceral - - - - - - - - - - - - - -
Chest/Abdo/Pelvis (Non-
Contrast)
- - - - - - - - - - - - - -
Thoracic Spine - - - - - - - - - - - - - -
Lumbar Spine 30 12.99 11.56 4.33 5.98 23.05 3.9 39 15.19 11.81 8.44 5.24 43.94 8.4
n = Number of cases included in analysis. Min = Minimum value, Max = Maximum value.
doi:10.1371/journal.pone.0138329.t002
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80 years. For this examination type the reduction in the number of cancers is less than 1 per
100,000 for those exposed aged over 25 years. In comparison, for non-contrast CT of the chest
Table 3. Evaluation of the effect of the introduction of iterative reconstruction (iDose) on dose length product (mGy.cm) and effective dose (mSv)
across CT protocols.

















Before After p value (% of original
if significant)





-174.93 -21% 33.72 11.50 <0.001* -0.36 -22% 34.83 11.50 <0.001*
Chest (Non-
Contrast)
-150.30 -35% 25.65 15.35 0.005* -3.14 -37% 25.60 15.40 0.006*
Chest PE Study -143.18 - 23.48 18.40 0.175 -2.81 - 23.57 18.30 0.159
Angiogram
Thoracic Aorta




52.81 - 19.25 21.75 0.499 1.22 - 18.55 22.45 0.291




-296.00 - 19.85 21.15 0.725 -0.63 -27% 26.10 14.90 0.002*
Chest (Non-
Contrast)
-210.70 -48% 24.10 15.68 0.021* -3.72 -47% 24.55 15.21 0.011*
Chest PE Study -214.91 -29% 25.15 15.85 0.012* -4.12 -28% 25.10 15.90 0.013*
Angiogram
Thoracic Aorta
229.62 - 17.00 23.16 0.092 4.92 - 17.35 22.79 0.136
Angiogram
Coronary




29.11 - 20.00 21.00 0.787 0.27 - 20.50 20.50 1.000
Angiogram
Visceral




-391.65 -39% 22.40 11.11 0.001* -2.81 -16% 22.50 11.05 0.001*
Thoracic Spine -402.35 41% 20.20 12.26 0.017* -8.25 -39% 20.50 12.11 0.012*




-197.32 -20% 51.31 38.24 0.018* -0.42 -22% 53.66 35.30 0.001*
Chest (Non-
Contrast)
-179.75 -41% 48.68 31.10 0.001* -3.41 -41% 48.93 30.85 <0.001*
Chest PE Study -176.17 - 45.98 35.90 0.054 -3.41 -28% 46.24 35.63 0.042*
Angiogram
Thoracic Aorta




40.96 - 38.95 42.05 0.551 0.74 - 38.63 42.38 0.470
(Continued)
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the reduction in mean effective dose of 3.14mSv translated to 31 and 85 fewer incident cancers
per 100,000 males and females respectively aged 15 years, reducing to 4 and 7 fewer incident
cancers per 100,000 males and females respectively aged 80 years (at examination). The magni-
tude of the differential impact according to Sex reduces substantially after approximately age
30 years; however, it remains present across all ages in this examination type.
Fig 2 shows changes in risk for examinations having a significant difference in mean effec-
tive dose in the tertiary hospital. It can be seen that the reduction in the mean effective dose in
head non-contrast examinations of 0.63mSv translated to an estimated reduction in the num-
ber of incident cancers of 12 and 13 per 100,000 males and females aged 15 years respectively,
reducing to a reduction of approximately one per 100,000 males and females aged 80 years.
The reduction in mean effective dose in Chest for PE study resulted in calculated reductions in
the estimated incidence of cancer of 40 and 118 per 100,000 males and females aged 15 years,
reducing to 5 and 10 per 100,000 males and females aged 80 years. The largest impact on can-
cer incidence was observed for CT of the thoracic spine where a reduction in the mean effective
dose of 8.25mSv resulted in calculated reductions in the estimated incidence of cancer of 78
and 215 per 100,000 males and females aged 15 years, reducing to 12 and 21 per 100,000 males
and females aged 80 years.
Fig 3 shows the impact on cancer incidence for the three examinations that showed a statis-
tically significant reduction in effective dose when undertaken at both hospitals. The reduction
of 0.42mSv in effective dose translated to a reduction in the estimated incidence of cancer of
Table 3. (Continued)

















Before After p value (% of original
if significant)
Before After p value
Lumbar Spine 137.03 - 31.60 37.62 0.217 2.19 - 34.13 35.67 0.753
1Dose length product, measured in mGy.cm
2Effective dose calculated using ImPACT in mSv
3Mean rank of DLP / Effective Dose before and following iDose. using the Mann Whitney U test (a rank-order (or nonparametric test) which assesses
whether the before and after scores have a similar ranked distribution).
4Statistical significance of the difference in the mean rank DLP / mean Effective Dose following iDose compared with prior to iDose (ie probability of the
scores belonging to a single group).
*Statistically significant (p<0.05) difference in mean rank DLP / Effective Dose following introduction of iDose.
doi:10.1371/journal.pone.0138329.t003
Fig 1. Change in the estimated number of incidence of cancers following installation of iterative
reconstruction software (iDose) in a secondary hospital for CT protocols showing a significant
change in mean effective dose.
doi:10.1371/journal.pone.0138329.g001
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4.8 and 4.5 per 100,000 males and females at age 15 reducing to 0.4 regardless of Sex at age 80
years. Similar reductions in the number of estimated incident cancers were produced for the
two chest examinations resulting from a reduction in mean effective dose of 3.41mSv with the
small difference due to variation in the average scan length. At age 15 the estimated incidence
of cancer reduced by 34 per 100,000 in males and 103 per 100,000 in females for the Chest PE
study and 33 per 100,000 in males and 93 per 100,000 females for the Chest non-contrast
study. At age 80 years the corresponding reductions were 5 and 8.5 per 100,000 males and
females (Chest PE study) and 4.5 and 8 per 100,000 males and females (Chest PE non-contrast
study).
Fig 2. Change in the estimated number of incidence of cancers following installation of iterative
reconstruction software (iDose) in a tertiary hospital for CT protocols showing a significant change in
mean effective dose.
doi:10.1371/journal.pone.0138329.g002
Fig 3. Change in the estimated number of incidence of cancers following installation of iterative
reconstruction software (iDose) in both a secondary and tertiary hospital for CT protocols showing a
significant change in mean effective dose.
doi:10.1371/journal.pone.0138329.g003
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Iterative Reconstruction Effect on the Estimated Number of Annual
Incident Cancers
Table 4 shows the reduction in the estimated number of annual incident cancers attributable to
introduction of iterative reconstruction software in WA restricted to examinations where a













Change in cancer incidence
rate per 100,000
Change in annual incidence of
cancer in WA2
Head (Non-Contrast)– Female 18–24 953 2,603 -3.5 -0.04
Both hospitals 25–44 4,154 10,654 -2.3 -0.11
45–64 6,558 14,779 -1.6 -0.11
65–84 9,565 14,267 -0.8 -0.06
85+ 6,579 2,642 -0.8 -0.02
Male 18–24 1,759 1,886 -3.8 -0.05
25–44 6,288 7,102 -2.5 -0.11
45–64 8,358 10,841 -1.8 -0.12
65–84 11,578 12,169 -0.8 -0.06
85+ 4,096 1,209 -0.8 -0.01
Total 59,888 78,152 -18.7 -0.71
Chest examinations Female 18–24 83 164 -64.1 -0.05
(non-contrast / PE
study)-
25–44 599 2,070 -37.9 -0.34
Both hospitals 45–64 2,028 8,376 -23 -0.80
65–84 2,798 9,269 -12.1 -0.49
85+ 414 864 -12.1 -0.05
Male 18–24 117 203 -24.1 -0.03
25–44 804 2,175 -16.6 -0.16
45–64 2,792 8,688 -12.7 -0.49
65–84 4,444 11,628 -7.1 -0.38
85+ 469 810 -7.1 -0.03
Total 14,548 44,247 -216.8 -2.81
Thoracic Spine – Female 18–24 34 40 -168.1 -0.04
Tertiary hospital 25–44 82 286 -106.4 -0.13
45–64 127 590 -67.9 -0.16
65–84 132 422 -36.1 -0.07
85+ 29 35 -36.1 -0.01
Male 18–24 109 55 -62.8 -0.03
25–44 312 360 -45.1 -0.10
45–64 244 474 -36.1 -0.09
65–84 151 271 -20.6 -0.03
85+ 20 14 -20.6 0.00
Total 1,240 2,547 -599.8 -0.66
1Change in effective dose scenario under which the change in the number of incident cancers in the population is calculated.
2Based on the average annual number of examinations conducted in WA 2010–12 assuming all examinations are conducted under the scenario specified.
doi:10.1371/journal.pone.0138329.t004
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significant reduction in effective dose was observed at both hospitals and Thoracic spine CT
since this examination produced the largest effect on lifetime attributable risk. The results indi-
cate that the impact of dose reduction depends on a combination of the magnitude of the
reduction, the radio-sensitivity of the tissues in the scanning field, the age and sex of the patient
and the volume of procedures undertaken. It can be seen that even though Head non contrast
CT scans are the most frequently performed (59,888 examinations 2010–2012) due to the rela-
tively small reduction in effective dose (-0.36mSv) and the relatively robust radio-sensitivity of
tissues included in the scanning field the impact of introduction of iterative reconstruction was
modest (0.71 fewer incident cancers annually). In contrast the number of Chest examinations
(non-contrast and PE studies) is much lower but due to the greater reduction in effective dose
(-3.41) and the relatively high radio-sensitivity of the organs the impact is greater (-2.81 inci-
dent cancers annually). Similarly although the largest reduction in effective dose (-8.25) and
reduction in risk (Fig 3) was observed for CT of the Thoracic spine due to the relatively low
number of examinations performed (2,547 between 2010–2012) the reduction in the estimated
number of incident cancers annually is lower than for Head non-contrast (-0.66). While these
annual reductions in cancers in WAmay at first appear low, especially with respect to Head
CT, when the change in cancer incidence rate per 100,000 is considered, the impact is substan-
tial and falls within values considered moderate to high in epidemiology. In addition, the esti-
mates produced in this analysis do not take into account the cumulative nature of the risk of
ionising radiation.
Discussion
This study has utilised a large clinical data set, multiple CT scanning protocols across two hos-
pitals to evaluate the magnitude of the change in radiation dosimetry (represented by DLP and
effective dose) attributable to the introduction of iterative reconstruction software into routine
clinical practice. It has also shown the potential effect these changes have in terms of risk bur-
den by evaluating the lifetime attributable risk of cancer incidence, highlighting that even mod-
est changes at the individual level can have large impact at the population level, particularly in
younger women. Our findings indicate CT radiation dose can be reduced using interactive
reconstruction techniques in day-to-day routine practice and these reductions can result in
substantial lowering of the lifetime attributable risk. However, we found the magnitude of
these reductions varied across anatomical site/protocol and was generally lower than indicated
by experimental studies reported in the literature.
Previous experimental studies have shown reductions in radiation dose of between 20% and
30% are achievable in Head CT[20, 21, 55]; 30% to 95% in Chest CT[22, 24, 25, 28, 37, 56–59];
40% to 65% in Abdominal CT[29–33] and 50% to 75% in CT Angiography[38, 40, 60] without
compromising diagnostic accuracy. In our study we observed statistically significant reductions
in the effective radiation dose for Head CT (22–27%) consistent with those reported in the lit-
erature. In contrast the reductions observed for Non-Contrast Chest CT (37–47%); Chest PE
CT (28%) and Thoracic spine CT (39%) were towards the lower end of the range reported as
achievable. The effective dose reduction observed in Chest/Abdo/Pelvis (Non-Contrast) CT
(16%) was below expectations; in addition to no observed effective dose reduction for Abdo-
men +/- Pelvis (Non-Contrast) CT. Our study observed no reductions in radiation dose for CT
angiography. This is discordant with findings from experimental studies that show large reduc-
tions are achievable for these examination types without loss of diagnostic accuracy.
We observed some discordance both across the two hospitals and across the metric used to
evaluate radiation dose (DLP and effective dose). In terms of DLP, for Head CT we observed a
statistically significant reduction of 21% in the secondary hospital but a non-significant
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reduction in the tertiary hospital. In contrast, in terms of effective dose we observed a statisti-
cally significant reduction for Head CT in both hospitals. A similar disparity between DLP and
effective dose is observed in Chest PE study CT. The findings highlight that reporting radiation
dose in terms of DLP, while easier to extract on a routine basis, is not the same as reporting it
in terms of effective dose. While a significant change in effective dose but not DLP may seem
intuitively contradictory it is important to understand the two measures are not 100% corre-
lated. A DLP value can remain the same if the scan length is increased or decreased proportion-
ally to any change in CT dose index volume (CTDIvol). However, DLP does not take in to
account the radiosensitivity of the organs and tissues exposed. Effective dose combines the
CTDIvol with the radiosensitivities of organs and tissues within the scan field to generate dose
estimates. It is possible changes in scan length, CTDIvol can see a reduction in effective dose
without a reduction in DLP by a narrowing of scan length to exclude radio sensitive organs
outside areas of clinical interest. This is unlikely to be a direct result of changes to protocols to
reduce dose using iterative reconstruction software. However, the introduction of iterative
reconstruction may have triggered a broader review of standard protocol settings which con-
tribute to effective dose.
The results for the two Chest CT protocols were also discordant across hospital sites. Statis-
tically significant reductions in both DLP (35% in secondary hospital, 48% in tertiary hospital)
and effective dose (37% in secondary hospital, 47% in tertiary hospital) were observed in both
hospitals for Non Contrast Chest CT. However, Chest CT PE study showed statistically signifi-
cant reductions of 29% for DLP and 28% for effective dose only in the tertiary hospital. When
the data were pooled across hospital site for procedures conducted at both sites, statistically sig-
nificant reductions were observed for Head CT and both Chest protocols (effective dose only
for Chest PE study) evaluated due to improved power resulting from the doubling of the sam-
ple size. However no significant difference was observed for CT angiography, abdominal or
lumbar spine studies when the data were pooled.
Our finding of mild to moderate reductions in radiation dose and no reduction in Abdomi-
nal or CT angiography suggests that while there is potential for substantial dose reduction
using iterative reconstruction radiologists may not be willing to reduce the radiation dose
thereby increasing the noise in some examinations in routine practice. The question posed by
our results is: why doses remained the same, despite the use of iterative reconstruction that
should have allowed doses to be significantly reduced, if the previous noise levels (i.e. prior to
iterative reconstruction) had been acceptable? At least two explanations are possible (i) CT
imaging factors were not modified following introduction of iterative reconstruction since
existing protocols were retained without consideration of the potential for dose reduction or
(ii) there was a conscious decision not to increase the image noise due to a belief that the
reduced noise of iterative reconstruction provided greater diagnostic accuracy.
Non-acceptance of higher noise images than achievable (limiting the realisation of dose
reduction) has been reported in the literature as an important challenge to the sustainability of
dose-reductions predicted by experimental studies.[44] A system of multidisciplinary optimi-
zation of the radiation dose/image quality over an extended period of time following introduc-
tion of iterative reconstruction mayimprove acceptance of higher image noise levels and
facilitate sustainable dose reduction.[44]
Nonetheless, the dose reductions observed in Head CT (both hospitals), Chest CT (both hospi-
tals) and Thoracic Spine CT (tertiary hospital only) did produce notable reductions in estimated
cancer incidence when applied to theWA state’s utilisation of these examinations and the wider
population impact. While this analysis does assume an unrealistic level of conformity from the
two hospitals included in the study to the entire state’s CT radiology providers, similar conformity
has been assumed during discussions regarding dose reductions achieved by experimental studies
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to promote the effectiveness of iterative software., The purpose of our analysis was not to quantify
‘actual’ reduction in population dose, rather it was to demonstrate the population level impact of
even small dose reductions. The cumulative efforts to reduce radiation dose from CT and other
medical radiation exposures without sacrificing clinical validity has the potential to produce large
cancer incidence rate changes at the population level.
Study Strengths and Limitations
A limitation of our study is that our method of estimating effective and organ dose did not
include size specific dose estimation (SSDE) methods since information regarding the body
habitus of the patients included in the study were not available. While it is important to
account for patient size when estimating individual patient radiation dose,[61] effective dose is
intended to represent the dose to a population of patients (as we have done in our study) not
individual patient dose.[62] This is an important distinction since effective dose is derived
from measurements in an idealized phantom that integrates the relative weighting of the radio-
sensitive organs exposed and does not reflect the morphometrics of an individual patient.[62]
All estimates of radiation dose have limitations, for example SSDE does not take into account
variations in dose based on variations in scan length, assumes patients are centred in the CT
gantry so that magnification effects are minimized and cannot be used for estimation of organ
dose, and thus cannot be used to estimate effective dose.[62] Thus while SSDE is recommended
and appropriate for estimating individual patient radiation dose it is not suitable when organ
and effective dose estimates are required and is not necessary when estimating the average radi-
ation dose characteristics of a particular examination i.e. examination specific rather than
patient specific dosimetry is required.
This study was restricted to evluattion of a single manufacturer, machine model and type of
iterative reconstruction. We acknowledge there are various forms of iterative reconstruction dif-
ferently employed by individual manufacturers of CTmachines and would likely produce differ-
ent reduction results than observed in this study. This study did not seek to compare types of
iterative reconstruction, rather it aimed to evaluate dose reduction in usual clinical practice (ie
outside of an experimental setting) while controlling the variation between scanning protocols as
best as possible by limiting the study to data from hospital departments which used the same
type of CTmachine (Philips Brilliance 64) and iterative reconstruction software.
A major strength of our study was the use of a random sample of CT patient data from an
administrative data set containing CT scans undertaken during routine clinical practice. We
aimed to estimate the average effective radiation dose for each adult CT protocol using a ran-
dom sample of adult patients. The random sampling methodology was used to capture the
underlying variation in doses produced for each scanning protocol at each time point and
avoid recall or selection bias associated with the use of survey methods. The timing of the data
collection was deliberately selected to allow for adequate time for each hospital to adjust and
settle on revised protocols (if at all) after the introduction of iterative reconstruction. The use
of actual scan parameters and dosimetry information recorded at the time of imaging rather
than reliance on self-selected mean doses, ‘standard’ protocols or phantoms facilitate a more
accurate representation of actual dose in practice (ensuring clinically accepted image quality
was achieved since all examinations included were those conducted under a usual practice set-
ting). Our data source and sampling method provide a more rigorous picture of real CT prac-
tice, rather than idealised or theoretical CT doses and practices obtained via experimental
studies.
Detailed information regarding patient numbers according to CT protocols from routinely
captured administrative data has allowed for cancer incidence attributable to CT scanning to
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be estimated. The estimates are extrapolations of the attributable cancer risk models developed
in the BEIR VII report[54] using standard Monte Carlo methods modelling photon transport
in CT. This study employs previously used methods to estimate risk and are the best available
data[63]. While the BEIR VII report provides a framework for estimating age, sex and organ
specific cancer risks from a radiation exposure it does not fully account for underlying pathol-
ogy and life expectancy. The BEIR VII risks should be considered representative of the inde-
pendent effect of radiation dose and can only be said to account for competing risks included
in the original BEIR VII models. The estimated number of incident cancers is presented here as
a demonstration of the magnitude of the effect on risk estimates attributed to the reduction in
radiation dose associated with the introduction of iterative reconstruction. There is substantial
difficulty in estimating population cancer risk as noted by the International Organization for
Medical Physics (IOMP)[64]. In our study the imprecision is equally applied to both dose sce-
narios (pre and post introduction) hence the magnitude of the effect reported is not affected by
the concerns of the IOMP. These concerns primarily rest with debate regarding acceptance of
the ‘linear, no-threshold theory’ for ionising radiation exposure risk. The linear, no-threshold
theory forms the foundation for radiation protection recommendations by international and
national committees.[52, 54, 65] Criticism of the linear, no-threshold theory rest on statistical
uncertainty for the relationship between radiation exposure and cancer incidence at low doses
(less than 100mSv).[52, 66] However, current biological evidence does not support a threshold
model where exposure to sub-100mSv radiation doses represents no risk.[54, 65, 67] Addition-
ally, other studies estimating the cancer incidence resulting from the independent effects of CT
radiation exposure have been published using the linear, no-threshold theory and BEIR-VII
LAR estimates.[68, 69] Therefore our study has employed conservative, clinically representa-
tive, peer-reviewed and internationally recognised methodology for dose and risk estimation.
Conclusion
Reduction of CT dose is a priority Iterative reconstruction algorithms have the potential to sig-
nificantly assist with dose reduction across a range of protocols. However, this reduction in
dose is achieved via reductions in image noise. Fully realising the potential dose reduction of
iterative reconstruction requires the adjustment of image factors and forgoing the noise reduc-
tion potential of the iterative algorithm. Our study has demonstrated a reduction in radiation
dose for some scanning protocols, but not to the extent experimental studies had previously
shown or in all protocols expected, raising questions about the extent to which iterative recon-
struction achieves dose reduction in real world clinical practice.
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